Medplus Health Services · NSE: MEDPLUS · BSE: 543427
Q2 FY26 results · Jul–Sep 2025
Medplus Health Services reported revenue from operations of ₹1,679.33 crore (up 6.5% from Q2 FY25) and net profit of ₹55.50 crore (up 43.4% from Q2 FY25) for Q2 FY26 (Jul–Sep 2025), on a consolidated basis.
| Item | Q2 FY26 | Q2 FY25 | YoY | Q1 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,679.33 | 1,576.17 | +6.5% | 1,542.63 | +8.9% |
| Other income | 17.47 | 11.60 | +50.6% | 15.02 | +16.3% |
| Total income | 1,696.80 | 1,587.77 | +6.9% | 1,557.65 | +8.9% |
| Profit before tax | 68.94 | 47.78 | +44.3% | 52.77 | +30.6% |
| Net profit for the period | 55.50 | 38.70 | +43.4% | 42.34 | +31.1% |
| EPS, basic (₹) | 4.63 | 3.24 | +42.9% | 3.54 | +30.8% |
| Net margin (%) | 3.3 | 2.5 | 2.7 |
| Item | Q2 FY26 | Q2 FY25 | YoY | Q1 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 205.65 | 156.23 | +31.6% | 183.88 | +11.8% |
| Other income | 2.94 | 2.25 | +30.6% | 2.65 | +11.1% |
| Total income | 208.59 | 158.48 | +31.6% | 186.53 | +11.8% |
| Profit before tax | 20.61 | 9.64 | +113.8% | 17.68 | +16.6% |
| Net profit for the period | 15.63 | 7.75 | +101.8% | 13.53 | +15.5% |
| EPS, basic (₹) | 1.31 | 0.65 | +101.5% | 1.13 | +15.9% |
| Net margin (%) | 7.6 | 5.0 | 7.4 |
Consolidated
- Filed with BSE
- 06 Nov 2025, 18:35 IST
- Board meeting
- 31 Oct 2025
- Period
- 01 Jul 2025 to 30 Sep 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 06 Nov 2025, 18:35 IST
- Board meeting
- 31 Oct 2025
- Period
- 01 Jul 2025 to 30 Sep 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE